ArticleMediators of inflammation2026
Role of Prokineticin-2 and Cytokines in Synovial Fluid in Traumatic Anterior Cruciate Ligament Injuries.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Role of Prokineticin-2 and Cytokines in Synovial Fluid in Traumatic Anterior Cruciate Ligament Injuries.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundAnterior cruciate ligament (ACL) tears induce a proinflammatory intra-articular environment. Despite successful ACL reconstruction (ACLR), post-traumatic osteoarthritis (PTOA) incidence remains high. The role of prokineticin-2 (PK2), a novel inflammatory and pain mediator, was investigated in this observational study of traumatic ACL injuries, associated with meniscal tears.
methodsTwenty patients with isolated ACL tears (ACL group) and 20 with associated meniscal injury (ACL + M group) were enrolled. Synovial fluid PK2, IL-10, and TNF-α levels were measured using ELISA method. Patients underwent long-term follow-up (minimum 5 years) with clinical reassessment using patient-reported outcome measures (PROMs) (IKDC, Lysholm, Tegner activity scale, SKV).
resultsPK2 was detected in both ACL and ACL + M groups without significant differences. Higher PK2 levels were associated with hemarthrosis and correlated positively with IL-10. No associations were found between PK2 levels and demographic factors or time from injury. At follow-up, PK2 negatively correlated with IKDC, Lysholm, and SKV scores.
conclusionThis study provides initial evidence of PK2 in synovial fluid following ACL injury, suggesting its potential role in knee inflammation. PK2 may represent a candidate biomarker involved in the post-traumatic inflammatory microenvironment; however, further longitudinal studies including structural outcomes are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.